ClinicalTrials.Veeva

Menu

Effect Of Virtual Reality Distraction on Symptom Control and Anxiety in Children With Leukemia (VR-Ege)

D

Dokuz Eylül University (DEU)

Status

Enrolling

Conditions

Symptom Cluster
Anxiety

Treatments

Device: virtual reality

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study aim to evaluate the effect of virtual reality distraction on symptom management and anxiety in children aged 7-18 years with leukemia.

Full description

While the virtual reality initiative was applied to the children in the study group, no harm was given to the children in the control group. The virtual reality distraction method will not be applied to the control group. After the child and his family are informed about the study, their written informed consent will be obtained.

When the patients were admitted to the clinic the day before chemotherapy treatment was started, the symptom screening scale and anxiety scale will be applied.

Control Group: The researcher stated that no additional procedure will be applied to the children in the control group and that the symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.

VR group; A distraction intervention will be applied for 10-15 minutes once a day with VR glasses. The symptom screening scale and anxiety measurement will be obtained by explaining that he/she should evaluate the scale every day for 3 days.

Enrollment

40 estimated patients

Sex

All

Ages

7 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pediatric patients aged 7-18 years receiving leukemia treatment in the Pediatric Hematology Service
  • 4 weeks after diagnosis (not in the induction phase)
  • No need for blood product transfusion (less than 8 mg/dl for hematological malignancies, less than 7 mg/dl for oncological malignancies)
  • Consent to voluntarily participate in the study and written consent from the child and parent

Exclusion criteria

  • The child has a physical and psychological deficit that will prevent him from wearing glasses to watch virtual reality
  • Having a symptom of nausea and vomiting
  • Being in a terminal period
  • Undergoing a surgical operation
  • Unwillingness to participate in the study
  • Having a history of vertigo (having a history of train, motion sickness)
  • The child and family do not know Turkish

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

virtual reality distraction
Experimental group
Description:
watching the application by wearing virtual glasses to the child during the 1st, 2nd and 3rd days of chemotherapy treatment
Treatment:
Device: virtual reality
control
No Intervention group
Description:
no virtual reality distraction

Trial contacts and locations

2

Loading...

Central trial contact

Gülçin Özalp Gerçeker, pHD; Gülçin Özalp Gerçeker, pHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems